| |
|
|
Description
Amisol™ Gold is a sterile aqueous solution of Amino Acids IV Infusion and
10% Glucose with electrolytes, which are necessary as the nitrogen sources
for parenteral nutrition. Nitrogen is provided in the form of essential and
non-essential amino acids.
Composition
Each 100 ml contains
|
Active
ingredients Specification
Quantity |
|
Essential Amino Acids |
|
L-Isoleucine
USP 0.390 g |
|
L-Leucine
USP
0.530 g |
|
L-Lysine
Hydrochloride USP
0.390 g |
|
L-Methionine
USP 0.190 g |
|
L-Phenylalanine USP
0.550 g |
|
L-Threonine
USP 0.300 g |
|
L-Tryptophan
USP
0.100 g |
|
L-Valine
USP
0.430 g |
|
L-Histidine
USP
0.240 g |
|
L-Tyrosine
USP
0.050 g |
|
Non-Essential Amino Acids |
|
L-Arginine
USP 0.330 g |
|
L-Aspartic
Acid USP
0.410 g |
|
L-Glutamic
Acid BP
0.900 g |
|
L-Alanine
USP 0.300 g |
|
L-Cystine
BP 0.140 g |
|
Glycine (Aminoacetic
Acid) USP 0.210 g |
|
L-Proline
USP
0.810 g |
|
L-Serine
USP
0.750 g |
|
|
|
Carbohydrate |
|
Anhydrous Glucose
BP 10.00 g |
|
|
|
Electrolytes (mmol/L) |
|
Potassium
Chloride BP
0.0375 g |
|
Calcium Chloride Dihydrate
BP 0.0368 g |
|
Magnesium Chloride Hexahydrate
BP 0.0305 g |
Pharmacology
Pharmacodynamics: Amino Acid IV Infusion with 10% Glucose and Electrolytes
contains amino acids and electrolytes, which are all present in ordinary
food. Apart from the nutritive properties Amino Acid IV Infusion with 10%
Glucose and Electrolytes should have no specific pharmacodynamic effects. To
optimize the utilization of supplied amino acids, adequate energy should be
supplied in the form of carbohydrates (preferably glucose) and fat.
Pharmacokinetics: The principle pharmacokinetic properties for Amino Acid IV
Infusion with 10% Glucose and Electrolytes are essentially the same as for
amino acids supplied by ordinary food. However, the amino acids of dietary
protein first enter the portal vein and then the systemic circulation, while
intravenously infused amino acids reach the systemic circulation directly.
Toxicology: Preclinical Safety Data: Preclinical safety studies with Amino
Acid IV Infusion with 10% Glucose and Electrolytes demonstrated good
tolerance.
Indications
As a source of amino acids, glucose and electrolytes in adult and pediatric
patients needing IV nutrition. Amino Acid IV Infusion with 10% Glucose and
Electrolytes is particularly suitable for patients with basal amino acids
requirements.
Dosage
Adults: The nitrogen requirement for maintenance of body protein mass
depends on the condition of the patient (nutritional state and degree of
metabolic stress). The requirements are 0.1-0.15 g nitrogen/kg body
weight/day (no or minor metabolic stress and normal nutritional state),
0.15-0.2 g nitrogen/kg body weight/day (moderate metabolic stress with or
without malnutrition) and up to 0.2-0.25 g nitrogen/kg body weight/day
(severe catabolism as in burns, sepsis and trauma). The dosage range
0.1-0.25 g nitrogen/kg body weight/day corresponds to 11-27 mL Amino Acid IV
Infusion with 10% Glucose and Electrolytes /kg body weight/day,
respectively. In obese patients, the dose should be based on the
estimated ideal weight. Depending upon patient requirements, up to 1000-2000
mL of Amino Acid IV Infusion with 10% Glucose and Electrolytes may be
infused IV per 24 hrs. Amino Acid IV Infusion with 10% Glucose and
Electrolytes should be infused slowly, at a rate not exceeding 1000 mL in 6
hrs corresponding to approximately 2.8 mL/min. In patients with basal amino
acids requirements, the less concentrated Amino Acid IV Infusion with 10%
Glucose and Electrolytes may be used. Infants and Children: In children and
infants, a maximal rate of infusion of 30 mL Amino Acid IV Infusion with 10%
Glucose and Electrolytes/kg body weight/day is recommended, with a stepwise
increase in the rate of administration during the 1st week of treatment.
Contraindications
Patients with inborn errors of amino acid metabolism, severe liver
dysfunction and in severe uremia when dialysis facilities are not available.
Due to the content of glucose, Amino Acids IV Infusion and 10% Glucose with
electrolytes is contraindicated in patients with hyperosmolar nonketotic
diabetic coma.
Precautions
IV infusion of amino acids is accompanied by increased urinary excretion of
the trace elements copper and, in particular zinc, which should be taken
into account in the dosing of trace elements, particularly during long-term
IV nutrition. Hyperphenylalaninemia has been noted in severely ill premature
infants. In these patients, monitoring of the phenylalanine level is
recommended and the infusion rate adjusted as needed. Amino Acids IV
Infusion and 10% Glucose with electrolytes should be used with caution in
patients with diabetes mellitus, severe heart failure or with renal function
in combination with fluid restrictions or oliguria/anuria of other origin.
In patients with hyperglycemia, administration of exogenous insulin might be
necessary. In severely malnourished patients refeeding carbohydrates can
trigger a thiamine (vitamin B1) deficiency syndrome. Those at high risk are
patients with a history of alcohol abuse, anorexia nervosa, prolonged
fasting or starvation and pregnant women with hyperemesis gravidarum. In
this kind of patients parenteral nutrition containing glucose should be
given with caution and parenteral administration of thiamine should be
considered before and during the administration of glucose. Monitoring of
serum potassium and blood glucose is recommended if Amino Acids IV Infusion
and 10% Glucose with electrolytes is infused rapidly or in a large quantity.
For patients with hypophosphatemia, an additional supply of phosphate is
recommended.
Use in Pregnancy
Animal reproduction studies or clinical investigations during pregnancy have
not been carried out with Amino Acids IV Infusion and 10% Glucose with
electrolytes. There are, however, published reports of successful and safe
administration of amino acid solutions during pregnancy.
Adverse Drug Reactions
Nausea occurs rarely. Transient increases in liver tests during IV nutrition
have been reported. The reasons are at present unclear. The underlying
disease and the components and their amounts in the IV feeding regimens have
been suggested. Hypersensitivity reactions have been reported with amino
acid solutions. As with all hypertonic infusion solutions, thrombophlebitis
may occur when peripheral veins are used. The incidence may be reduced by
the simultaneous infusion of Intralipid. Extravascular disposition may cause
tissue necrosis. Hyperphenylalaninemia may occur in severely ill, premature
infants.
Drug Interactions
Not to be expected.
Overdosage
If Amino Acid IV Infusion with 10% Glucose and Electrolytes is administered
at a higher rate than recommended, there is an augmented risk for nausea,
vomiting and sweating. When peripheral veins are used thrombophlebitis may
occur. Osmotic diuresis with dehydration may occur if the dosage
recommendations are exceeded. There is also a risk of symptoms related to
hyperglycemia with Amino Acid IV Infusion with 10% Glucose and Electrolytes.
In case of symptoms due to overdose, the infusion should be slowed down or
discontinued.
Pharmaceutical Precautions
Protect from light and store between 150C to 250C temperature. Avoid
freezing. Keep medications out of reach of children.
Commercial Pack
Amisol™ Gold is available in 500 ml glass bottle.
|
|
|